Page 19 - RPIA_26-2

ASMA GRAVE E MACRÓLIDOS / ARTIGO DE REVISÃO

Contacto 14. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W,
Alexandru Ciobanu Sousa A. Mepolizumab and exacerbations of refractory eosino-
Serviço de Imunoalergologia philic asthma. N Engl J Med 2009;360:973 -84.
Centro Hospitalar e Universitário de Coimbra 15. Brooks C, Van Dalen C, Zacharasiewicz A, Simpson J, Harper J,
E-mail: aleksandrcio@yahoo.com Le Gros G, et al. Absence of airway inflammation in a large pro-
portion of adolescents with asthma. Respirology 2016;21:260 -8.
16. Moore W, Hastie A, Li X, Li H, Busse W, Jarjour N, et al. Sputum
REFERÊNCIAS neutrophil counts are associated with more severe asthma pheno-
types using cluster analysis. J Allergy Clin Immunol 2014;133:1557 -63.
1. Global Initiative for Asthma. Global strategy for asthma manage- 17. Nair P, Gaga M, Zervas E, Alagha K, Hargreave F, O’Byrne P, et
ment and prevention. 2017.http://ginasthma.org/2017 -gina -report- al. Safety and efficacy of a CXCR2 antagonist in patients with
global -strategy -for -asthma -managementand prevention. Acedido severe asthma and sputum neutrophils: a randomized, placebo-
em 26/07/2017. -controlled clinical trial. Clin Exp Allergy 2012;42:1097 -103.
2. Tomaz E, Cardoso B. Asma grave. Em: Todo Bom A. Asma.1st 18. Chaudhuri R, Norris V, Kelly K, Zhu C, Ambery C, Lafferty J, et
ed. Lisboa: Lidel; 2016: 281 -91. al. Effects of a flap inhibitor, GSK2190915, in asthmatics with high
3. Lockey RF. Asthma phenotypes: An approach to the diagnosis sputum neutrophils. Pulm Pharmacol Ther 2014;27:62 -9.
and treatment of asthma. J Allergy Clin Immunol Pract. 2014; 19. Simpson JL, Milne DG, Gibson PG. Neutrophilic asthma has dif-
2(6):682 -5. ferent radiographic features to COPD and smokers. Resp Med
4. Chaves Loureiro C. Fenótipos e endótipos de asma no adulto. 2009;103:881 -7.
Em: Todo Bom A. Asma.1st ed. Lisboa: Lidel; 2016: 55 -63. 20. Nair P, Aziz -Ur -Rehman A, Radford K. Therapeutic implications
5. Mota Pinto A, Neuparth N, Todo Bom A. Fisiopatologia da asma. of ‘neutrophilic asthma’. Curr Opin Pulm Med 2015;21:33 -8.
Em: Todo Bom A. Asma.1st ed. Lisboa: Lidel; 2016: 45 -54. 21. Schleich F, Manise M, Sele J, Henket M, Seidel L, Louis R. Distri-
6. Reis Ferreira A, Moreira da Silva JP. Classificação da asma. Em: bution of sputum cellular phenotype in a large asthma cohort:
Todo Bom A. Asma.1st ed. Lisboa: Lidel; 2016: 157 -161. predicting factors for eosinophilic vs neutrophilic inflammation.
7. The ENFUMOSA cross -sectional European multicentre study of BMC Pulm Med 2013;13:11.
the clinical phenotype of chronic severe asthma. Eur Respir J 22. Wood L, Baines K, Fu J, Scott H, Gibson P. The neutrophilic in-
2003;22:470 -7. flammatory phenotype is associated with systemic inflammation
8. Moore WC, Bleecker ER, Curran -Everett D, Erzurum SC, Amere- in asthma. Chest 2012;142:86 -93.
des BT, Bacharier L, et al. Characterization of the severe asthma 23. Newcomb D, Peebles Jr R. Th17 - mediated inflammation in asth-
phenotype by the National Heart, Lung, and Blood Institute’s ma. Curr Opinion Immunol 2013;25:755 -60.
Severe Asthma Research Program. J Allergy Clin Immunol 24. Furukawa T. Characteristics of eosinophilic and non -eosinophilic
2007;119:405 -13. asthma during treatment with inhaled corticosteroids.J Asthma.
9. Haselkorn T, Borish L, Miller DP, Weiss ST, Wong DA. High 2015;52:417 -22.
prevalence of skin test positivity in severe or difficult -to -treat 25. Shen N, Wang J, Zhao M, Pei F, He B. Anti -interleukin -17 antibo-
asthma. J Asthma 2006;43:745 -52. dies attenuate airway inflammation in tobacco -smoke -exposed
10. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et mice. Inhal Toxicol 2011;23:212 -8.
al. International ERS/ATS guidelines on definition, evaluation and 26. Chesné J, Braza F, Mahay G, Brouard S, Aronica M, Magnan A.
treatment of severe asthma. Eur Respir J 2014;43:343 -73. IL -17 in severe asthma. Where do we stand? Am J Respir Crit
11. Barata L, Luís A, Inácio F. Fenótipos de asma grave. Em Vaz M. Care Med 2014;190:1094 -101.
Recomendações para diagnóstico e terapêutica de asma grave em 27. Lemière C, Tremblay C, Fitzgerald M, Aaron S, Leigh R, Boulet
Portugal, 2010:35 -52. Disponível em: http://pesquisabmc.cm -coimbra. L, et al. Effects of a short course of inhaled corticosteroids in
pt/docbweb2/plinkres.asp?Base=ISBD. Acedido em 26/07/2017. noneosinophilic asthmatic subjects. Can Respir J 2011;18:278 -82.
12. Green RH1, Brightling CE, McKenna S, Hargadon B, Parker D, 28. Maneechotesuwan K, Essilfie -Quaye S, Kharitonov, Adcock I,
Bradding P, et al. Asthma exacerbations and sputum eosinophil Barnes P. Loss of control of asthma following inhaled corticoste-
counts: a randomised controlled trial. Lancet 2002;360:1715 -21. roid withdrawal is associated with increased sputum interleukin -8
13. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. and neutrophils. Chest 2007;132:98 -105.
Diagnosis and definition of severe refractory asthma: an interna- 29. Wang F, He X, Baines K, Gunawardhana L, Simpson J, Li F, et al.
tional consensus statement from the Innovative Medicine Initiative Different inflammatory phenotypes in adults and children with
(IMI). Thorax 2011;66:910 -7. acute asthma. Eur Respir J 2011;38:567 -74.

95

REVIST A POR TUGUESA DE IMUNO ALERGOLOGIA